Spectrum Pharmaceuticals Inc (SPPI)

Trade SPPI now with
2/5/2018 7:06:44 AM Spectrum Pharma: ROLONTIS (eflapegrastim) Met Primary Endpoint In Phase 3 ADVANCE Study
12/18/2017 11:59:34 AM B. Riley Initiates Spectrum Pharmaceuticals Inc (SPPI) At Buy With $26 Price Target
12/13/2017 7:04:01 AM Spectrum Pharma Highlights Two Oral Presentations On FOLOTYN At ASH
10/30/2017 7:10:29 AM Spectrum Begins Multicenter Phase 2 Trial Of Poziotinib In NSCLC Patients With Exon 20 Insertion Mutation In EGFR
10/17/2017 10:29:09 PM Spectrum Pharma Highlights Poziotinib Data In Non-Small-Cell Lung Cancer Presented
10/10/2017 7:10:56 AM Spectrum Announces Agreements To Exchange $69.5 Mln Of Its 2.75% Convertible Senior Notes Due 2018
8/14/2017 7:12:03 AM Spectrum Pharma Says Begins Registrational Phase 3 Trial Of Qapzola In Patients With Non-Muscle Invasive Bladder Cancer
6/19/2017 7:05:17 AM Spectrum Pharma Highlights Results Of A Combination Study Of FOLOTYN Plus Romidepsin
4/6/2017 6:14:20 AM Jefferies Is Raising Spectrum Pharmaceuticals Inc (SPPI) 2017 Estimate To -0.98 From -1.00